Subscribe to Updates in Healthcare

RSS By Email

RSS By RSS

Add to Google Reader or Homepage

Subscribe in Bloglines


The Expertise Imperative and Compliance Technology
Access to a diverse array of specialized expert inputs drives superior decisions in every organizational context: within corporations, by investors and consultancies, and within nonprofits. When decision makers are confident of their decision inputs, they can respond more quickly and creatively to challenges and opportunities.Learn more about GLG's Compliance Framework


This page may include content provided by Council Members, your access to which is subject to the Terms of Use.
Find Out More

Study Group: Rheumatologists(?)

Council Members in this Study Group: 870

This study group may include physicians, care providers, and researchers specializing in internal medicine, cardiology, oncology, dermatology, emergency medicine, family medicine, neurology, obstetrics-gynecology, psychiatry, radiology, nursing, optometry, genetics, and mental health. It may also include experts knowledgeable on diagnostic labs, disease management, medical devices, long term care, surgery centers, health management, pharma, and biotechnology, among others.

Request a survey with this Study Group







Leading Experts in this Study Group

Ara Dikranian, MD
Partner
San Diego Arthritis Medical Clinic

Ara Dikranian, MD, is a Rheumatologist at San Diego Arthritis Medical Clinic, a single-specialty private practice in San Diego, California. Dr. Dikranian is board certified in Internal Medicine and Rheumatology. He completed his rheumatology training at the University of California San Diego. He has...

David Mandel, MD
Physician
Mandel, David R Md

David Mandel, MD, is a rheumatologist in private practice. He has expertise in clinical research and is a thought leader in the field of osteoporosis and has published many articles on rheumatoid arthritis and osteopoprosis and speaks to both community and medical organizations extensively. He has been...

Herbert Baraf, MD, FACP, FACR, Clinical Associate Professor of Medicine, UNIVERSITY OF MARYLANDHerbert Baraf, MD, FACP, FACR
Clinical Associate Professor of Medicine
UNIVERSITY OF MARYLAND

Herbert Baraf, MD, FACP, FACR, is the Managing Partner of Arthritis and Rheumatism Associates and the Medical Director of Center for Rheumatology and Bone Research in Maryland. He is also the Clinical Professor of Medicine at George Washington University Medical Center and Clinical Associate Professor...

Dipti Doshi, MD
Rheumatologist
HEALTHCARE PARTNERS MEDICAL GROUP

Dipti Doshi, MD, is a board certified Rheumatologist at Health Care Partners Medical group, California. Dr. Doshi is also board certified in Internal Medicine. Her special interests are in rheumatoid arthritis, lupus, pain-related to scleroderma, fibromyalgia, and osteoarthritis. Dr. Doshi is interested...

Avram Goldberg, MD,FACR, Assistant Professor , Albert Einstein College of MedicineAvram Goldberg, MD,FACR
Assistant Professor
Albert Einstein College of Medicine

Avram Goldberg, MD, FACR, is an Attending Physician at North Shore University Hospital and an Assistant Professor at the Albert Einstein College of Medicine, New York. He is part of the Division of Rheumatology where he is responsible for treatment of autoimmune and musculoskeletal diseases including...

Kenneth Nies, MD, FACP
Rheumatologist
Arthritis and Osteoporosis Treatment Center

Kenneth Nies, MD, FACP, is a Clinical Professor of Medicine at the University of California Los Angeles and is also in private practice at the Arthritis and Osteoporosis Treatment Center in Torrance, California. In addition to his clinical work, his background includes 10 years of academic medicine...

Daniel Furst, MD
Carl M. Pearson Chair of Rheumatology
UNIVERSITY OF CALIFORNIA LOS ANGELES

Daniel Furst, MD, is the Carl M. Pearson Chair of Rheumatology and Director of Interventional Therapeutics at University of California, Los Angeles Medical Center for Health Sciences. Dr. Furst has expertise in clinical pharmacology of anti-rheumatic drugs, scleroderma, and rheumatoid arthritis.

GLG NewsSMAnalyses by this Study Group's Leading Experts(?)

Opinions and analyses expressed in GLG News are solely those of the author. See the Terms of Use for details.
Pain Relief with Ulcers, Strokes or Heart Attacks: Pick your poison! | 11-19-2008
Analysis of: Painkiller Risk Found for Heart Patients | www.nytimes.com
Author: GLG Expert Contributor

Nsaids are the most common therapy for arthritis and related pain problems. But in all forms they have up to a 2% risk of fatal GI bleeds. COX2 Nsaids such a Celebrex and COX2 related Voltaren have the lower risk of GI bleeds but a higher risk of cardiovascular complications. Proton pump acid suppressants...

Tamper proof narcotic | 11-17-2008
Analysis of: FDA Asks if Pain Pill Is Tamper-Proof | online.wsj.com
Author: GLG Expert Contributor

The principles look sound and should thwart all but the most sophisticated addicts. It would probably take good knowledge of organic chemistry to separate the two components.  Unfortunately, this will all come with increased cost over conventional 'unprotected' opiates and struggles ...

Celebrex and Heart Attacks - Nexium and Plavix combination. | 11-17-2008
Analysis of: Painkiller Risk Found for Heart Patients | www.nytimes.com
Author: GLG Expert Contributor

Will the sale of Celebrex be hurt by a rehashing of old data? Overly simplified negative news coverage frightens patients and reduces those willing to take the drug.  If they should agree to take it after counseling and be one of those who suffer a heart attack for what ever...

Patients will continue to decrease the use of these agents for reasons that I can speculate are largely related to lack of perceived efficacy the fear of the unknown | 07-28-2008
Analysis of: Drugs to Build Bones May Weaken Them | www.nytimes.com
Author: GLG Expert Contributor

This should not deter the practicing physician to prescribe these agents osteoporosis will reach epidemic proportions and if we can reduce fractures by 50% the savings within the healthcare system will be enormous that's not to say that individuals albeit rare may have a propensity to develop fractures...

Over Suppression of Bone Turnover May Be Harmful | 07-21-2008
Analysis of: Drugs to Build Bones May Weaken Them | www.nytimes.com
Author: GLG Expert Contributor

Bisphosphonates, including medications like Fosamax, prevents normal bone turnover and metabolism.  Nephrologists had anticipated similar findings as these recent reports as over-suppression of normal bone turnover may be associated with adynamic bone disease and possibly fractures.  The process...

View All GLG News by members of this Study Group

Most Common Company Types:

  • Academic Medical Center/Hospital or Clinic
  • Office Based Private Practice or Clinic
  • Non-Academic Community Hospital or Clinic
  • Academic Institution*
  • Government/Military Hospital or Clinic

Most Common Job Types:

  • Physician - Attending Physician
  • Physician - Division Head
  • Physician - Director
  • Owner
  • Director

GLG's 750+ Clients Include:

40 of the leading 50
global mutual funds
15 of the leading 20
global banks
8 of the leading 10
private equity firms
90%+ client subscription renewal rate

Analytics


Generated at 2008-11-21T05:45:43.110